Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21
Phase 41

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03066258Phase 1/2Completed
Safety and Tolerability of RGX-314 (Investigational Product) Gene Therapy for Neovascular AMD Trial
Neovascular Age-related Macular DegenerationWet Age-related Macular Degeneration
PrincipalinvestigatorStart date: 2017-03-29

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mingwei Zhao, PhD

Peking University People's Hospital

Related
3 trials

Shared therapeutic areas:

Wet Age-Related Macular DegenerationNeovascular Age-related Macular Degeneration
Similarity Score20%

Harvey S Uy, MD

Peregrine Eye and Laser Institute

Related
4 trials

Shared therapeutic areas:

Neovascular Age-related Macular DegenerationVitrectomy
Similarity Score20%

Byung Jhip Ha

Sam Chun Dang Pharm. Co. Ltd.

Related
2 trials

Shared therapeutic areas:

Neovascular Age-related Macular DegenerationWet Age-Related Macular Degeneration
Similarity Score20%

Xiaorong Li, professor

Tianjin Medical University Eye Hospital

Related
5 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score10%

Jamie Dananberg, MD

UNITY Biotechnology

Related
2 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score10%

Se Joon Woo

Seoul National University Bundang Hospital, South Korea

Related
2 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score10%

youxin chen, MD

Peking Union Medical College Hospital

Related
2 trials

Shared therapeutic areas:

Wet Age-Related Macular Degeneration
Similarity Score10%

Chung-May Yang, MD

National Taiwan University Hospital

Related
9 trials

Shared therapeutic areas:

Vitrectomy
Similarity Score10%

Federico Grossi, MD PhD

Apellis Pharmaceuticals, Inc.

Related
2 trials

Shared therapeutic areas:

Neovascular Age-related Macular Degeneration
Similarity Score10%

Denis O'Shaughnessy, Ph.D.

Oraya Therapeutics, Inc.

Related
2 trials

Shared therapeutic areas:

Wet Age-Related Macular Degeneration
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03066258Phase 1/2PrincipalInvestigator

Safety and Tolerability of RGX-314 (Investigational Product) Gene Therapy for Neovascular AMD Trial

Neovascular Age-related Macular DegenerationWet Age-related Macular Degeneration
Completed
NCT00377546Phase 4PrincipalInvestigator

Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%

Vitrectomy
Completed

All 2 trials loaded